2011 News Releases
November 21, 2011
Biothera Names Patricia Molloy, M.D., Chief Medical Officer
November 17, 2011
Biothera Phase II Lung Cancer Trial Fully Enrolled
August 29, 2011
LaFrence Joins Biothera Board of Directors
June 27, 2011
Research: Molecular Differences in Biothera β-Glucans Impact Immune Cell Responses
June 22, 2011
Biothera Presents Cancer Data at European Society for Medical Oncology
May 18, 2011
Biothera Initiates Dosing in Phase III Colorectal Cancer Trial
April 27, 2011
New Research on Biothera Beta Glucans is Published in Nature
April 19, 2011
Biothera Phase II Lung Cancer Trials Achieve Stage 1 Goals
April 19, 2011
March 14, 2011
Phase I/II Clinical Trial in Chronic Lymphocytic Leukemia to Evaluate Combination Therapy with Biothera’s Imprime PGG
March 10, 2011
Biothera Acquires MUC1 Anti-Cancer Monoclonal Antibody from Antisoma
March 7, 2011
Biothera Names William J. Grossman, M.D., Ph.D., SVP of Research & Development